Aprogen, Inc Logo

Aprogen, Inc

Develops and manufactures biologic medicines, including biosimilars and novel drugs.

007460 | KO

Overview

Corporate Details

ISIN(s):
KR7007460009
LEI:
Country:
South Korea
Address:
경기도 성남시 중원구 둔촌대로 545 경기도 성남시 중원구 둔촌대로545, 비1층 (상대원동, 한라시그마밸리), 성남시

Description

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-02-23 00:00
[기재정정]유상증자결정(종속회사의주요경영사항)
Korean 51.8 KB
2024-02-22 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 14.4 KB
2024-02-16 00:00
주식등의대량보유상황보고서(일반)
Korean 125.2 KB
2024-02-13 00:00
주식등의대량보유상황보고서(약식)
Korean 69.8 KB
2024-02-05 00:00
투자판단관련주요경영사항 (AP063(허셉틴 바이오시밀러) 임상3상 시험계획 승인(유럽 이외 기타 지역(인도)))
Korean 11.7 KB
2024-02-01 00:00
주식등의대량보유상황보고서(일반)
Korean 119.1 KB
2024-01-30 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 10.8 KB
2024-01-19 00:00
주식등의대량보유상황보고서(일반)
Korean 122.6 KB
2024-01-19 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 66.7 KB
2024-01-19 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-01-19 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.2 KB
2024-01-12 00:00
감자결정(종속회사의주요경영사항)
Korean 14.9 KB
2024-01-12 00:00
유상증자결정(종속회사의주요경영사항)
Korean 31.1 KB
2024-01-10 00:00
투자판단관련주요경영사항(특허권 취득)
Korean 13.7 KB
2024-01-09 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 66.7 KB

Automate Your Workflow. Get a real-time feed of all Aprogen, Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aprogen, Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aprogen, Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.